× NICE uses cookies to make the site better.  Learn more
A-Z
Topics
Latest


Renal cancer

About

What is covered

This interactive flowchart covers renal cancers.

Updates

Updates to this interactive flowchart

21 February 2017 Everolimus for advanced renal cell carcinoma after previous treatment (NICE technology appraisal guidance 432) added to second-line treatment for advanced and metastatic renal cancer.
22 November 2016 Nivolumab for previously treated advanced renal cell carcinoma (NICE technology appraisal guidance 417) added to second-line treatment for advanced and metastatic renal cancer.
24 February 2015 Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment (NICE technology appraisal guidance 333) added to second-line treatment for advanced and metastatic renal cancer.
31 October 2014 Single-port laparoscopic nephrectomy (NICE interventional procedures guidance 414) added to procedures for treating renal cancer.

Your responsibility

Guidelines

The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take these recommendations fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this interactive flowchart is not mandatory and does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the interactive flowchart to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this interactive flowchart should be interpreted in a way that would be inconsistent with compliance with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

Technology appraisals

The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take these recommendations fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this interactive flowchart is at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Commissioners and/or providers have a responsibility to provide the funding required to enable the recommendations to be applied when individual health professionals and their patients wish to use it, in accordance with the NHS Constitution. They should do so in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

Medical technologies guidance, diagnostics guidance and interventional procedures guidance

The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take these recommendations fully into account. However, the interactive flowchart does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
Commissioners and/or providers have a responsibility to implement the recommendations, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this interactive flowchart should be interpreted in a way that would be inconsistent with compliance with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

Person-centred care

People have the right to be involved in discussions and make informed decisions about their care, as described in your care.
Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.

Short Text

Everything NICE has said on renal (kidney) cancer in an interactive flowchart

What is covered

This interactive flowchart covers renal cancers.

Updates

Updates to this interactive flowchart

21 February 2017 Everolimus for advanced renal cell carcinoma after previous treatment (NICE technology appraisal guidance 432) added to second-line treatment for advanced and metastatic renal cancer.
22 November 2016 Nivolumab for previously treated advanced renal cell carcinoma (NICE technology appraisal guidance 417) added to second-line treatment for advanced and metastatic renal cancer.
24 February 2015 Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment (NICE technology appraisal guidance 333) added to second-line treatment for advanced and metastatic renal cancer.
31 October 2014 Single-port laparoscopic nephrectomy (NICE interventional procedures guidance 414) added to procedures for treating renal cancer.

Sources

NICE guidance and other sources used to create this interactive flowchart.
Improving outcomes in urological cancers (2002) NICE guideline CSG2
Everolimus for advanced renal cell carcinoma after previous treatment (2017) NICE technology appraisal guidance 432
Nivolumab for previously treated advanced renal cell carcinoma (2016) NICE technology appraisal guidance 417
Pazopanib for the first-line treatment of advanced renal cell carcinoma (2011 updated 2013) NICE technology appraisal guidance 215
Irreversible electroporation for treating renal cancer (2013) NICE interventional procedures guidance 443
Single-port laparoscopic nephrectomy (2011) NICE interventional procedures guidance 414
Laparoscopic cryotherapy for renal cancer (2011) NICE interventional procedures guidance 405
Percutaneous cryotherapy for renal cancer (2011) NICE interventional procedures guidance 402
Percutaneous radiofrequency ablation for renal cancer (2010) NICE interventional procedures guidance 353
Laparoscopic partial nephrectomy (2006) NICE interventional procedures guidance 151
Laparoscopic nephrectomy (including nephroureterectomy) (2005) NICE interventional procedures guidance 136

Quality standards

Quality statements

Effective interventions library

Effective interventions library

Successful effective interventions library details

Implementation

Information for the public

NICE produces information for the public that summarises, in plain English, the recommendations that NICE makes to healthcare and other professionals.
NICE has written information for the public explaining its guidance on each of the following topics.

Pathway information

Your responsibility

Guidelines

The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take these recommendations fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this interactive flowchart is not mandatory and does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the interactive flowchart to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this interactive flowchart should be interpreted in a way that would be inconsistent with compliance with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

Technology appraisals

The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take these recommendations fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this interactive flowchart is at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Commissioners and/or providers have a responsibility to provide the funding required to enable the recommendations to be applied when individual health professionals and their patients wish to use it, in accordance with the NHS Constitution. They should do so in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

Medical technologies guidance, diagnostics guidance and interventional procedures guidance

The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take these recommendations fully into account. However, the interactive flowchart does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
Commissioners and/or providers have a responsibility to implement the recommendations, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this interactive flowchart should be interpreted in a way that would be inconsistent with compliance with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

Person-centred care

People have the right to be involved in discussions and make informed decisions about their care, as described in your care.
Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.

Supporting information

Glossary

Eastern Cooperative Oncology Group

Paths in this pathway

Pathway created: December 2013 Last updated: May 2017

© NICE 2017

Recently viewed